Alerts will be sent to your verified email
Verify EmailQLINE
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Q-Line Biotech Limited, incorporated in 2010, is engaged in developing, manufacturing, and marketing diagnostic reagents, kits, consumables, and IVD equipment for healthcare applications, serving diagnostic laboratories, hospitals, and medical colleges across multiple pathology segments.
Q-Line Biotech major competitors are Poly Medicure, Tarsons Products, Morepen Laboratories, Nureca Ltd..
Market Cap of Q-Line Biotech is ₹1,189 Crs.
While the median market cap of its peers are ₹2,068 Crs.
Q-Line Biotech seems to be less financially stable compared to its competitors.
Altman Z score of Q-Line Biotech is 4.61 and is ranked 4 out of its 5 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Claude
|
